The human microbiome confers benefits or disease susceptibility to the human body through
multiple pathways. Disruption of the symbiotic balance of the human microbiome is …

The correlations between microbiota dysbiosis and cancer have gained extensive attention
and been widely explored. As a leading cancer diagnosis worldwide, lung cancer poses a …

Over the past decade, revolution in microbial research has provided valuable insights into
the function of microbes that inhabit human body. This complex community of microbes …

Background Lung cancer is the leading cause of cancer-related deaths worldwide (Ferlay et
al., Int J Cancer 136: E359–386, 2015). In addition, lung cancer is associated with the …

Commensal microbiota has emerged as an essential biomarker and regulator of both
tumorigenesis and response to cancer therapy. However, our current knowledge about …

The influence of microbiota on host health and disease has attracted adequate attention,
and gut microbiota components and microbiota-derived metabolites affect host immune …

Lung cancer (LC) is one of the most serious malignant tumors, which has the fastest growing
morbidity and mortality worldwide. A role of the lung microbiota in LC pathogenesis has …

The microbiota is increasingly recognized as a critical player in cancer onset and
progression and response to cancer chemotherapy treatment. In recent years, several …

The gut microbiota (GM) is considered to constitute a powerful “organ” capable of
influencing the majority of the metabolic, nutritional, physiological, and immunological …

Until recently, bacteria have been studied in terms of their roles in infectious diseases and
mainly by using isolation and culture methods. However, in practice, many bacteria existing …